| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Apr 11, 2024 | Sale | $6.74 | 54 | 364 | 70,849 | Apr 12, 2024, 04:05 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Jan 23, 2024 | Sale | $9.07 | 853 | 7,735 | 49,721 | Jan 25, 2024, 04:10 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Sep 05, 2023 | Sale | $14.71 | 457 | 6,723 | 50,574 | Sep 05, 2023, 08:15 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | May 10, 2023 | Sale | $16.59 | 455 | 7,548 | 51,031 | May 12, 2023, 04:14 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Apr 11, 2023 | Sale | $21.49 | 47 | 1,010 | 51,486 | Apr 13, 2023, 04:07 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Feb 01, 2023 | Sale | $21.75 | 1,588 | 34,542 | 51,533 | Feb 02, 2023, 07:02 PM | |
| TVTX | Travere Therapeutics, Inc. | Cline Christopher R. | Chief Financial Officer | Jan 24, 2023 | Sale | $21.90 | 852 | 18,663 | 32,871 | Jan 26, 2023, 04:05 PM |
Menu